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2Abstract
Background Children born after medically assisted reproduction (MAR) are at higher risk of
adverse birth outcomes than naturally conceived children. It is not known to what extent the
excess risk should be attributed to harmful effects of the treatment or to pre-existing parental
characteristics that confound the association.
Methods We analysed birth weight, gestational age, risk of low birth weight, and risk of
preterm birth among MAR- and naturally conceived children using Finnish population
registers covering 65,723 children born in 1995-2000. First, we estimated the differences in
birth outcomes by mode of conception in the general population using standard multivariate
methods that controlled for observed factors (e.g., multiple birth, birth order, and parental
socio-demographic characteristics). Second, we used a sibling-comparison approach that has
not been used before in MAR research. We compared MAR-conceived children to their
naturally conceived siblings, and thus controlled for all observed and unobserved factors
shared by siblings. The latter analysis included 1245 children.
Findings MAR-conceived children had worse outcomes than naturally conceived children for
all outcomes, even after adjustments for observed child and parental characteristics (e.g., 60gr
[95% CI: -34 to -86] lower birth weight; 2.15-percentage point [95% CI: 1·07 to 3·24]
increased risk of preterm delivery). In the sibling comparison, the gap in birth outcomes was
attenuated, such that the relationship between MAR and adverse birth outcomes was
statistically and substantively weak for all outcomes (e.g., 31gr [95% CI: -22 to 85] lower
birth weight; 1.6 percentage points [95% CI: -1·3% to 4·4%] increased risk of preterm
delivery).
Interpretation MAR-conceived children face an elevated risk of adverse birth outcomes.
However, our results indicate that this increased risk is largely attributable to factors other
than the MAR treatment itself.
Funding European Research Council, the Academy of Finland, and the Signe and Ane
Gyllenberg Foundation.
3Research in context
Evidence before this study
We searched for studies analysing the association between Medically Assisted Reproduction
and birth outcomes within families who had at least one child conceived through MAR and
one child conceived naturally, published in any language up until March 2018 (with no
specified earliest date). We searched in PubMed and Google Scholar using relevant terms
(“Medically Assisted Reproduction”, “Assisted Reproductive Technology”, “birth
outcomes”, “low birth weight”, “preterm”, “siblings”, “within family”). We found only three
studies that compared MAR- and naturally conceived children from the same families. These
studies, which reported mixed findings, suffered from two major limitations. First, they relied
on random-effects models, which are biased when unobserved random effects (e.g.,
measuring health) are correlated with observed covariates (e.g., maternal age, socioeconomic
status). Second, they focused on children conceived through IVF only, and included children
born after other fertility treatments (ovulation induction or artificial insemination) in the
naturally conceived group. This approach may have biased the estimated MAR effects
towards zero, as children conceived through other MAR treatments have worse birth
outcomes than naturally conceived children.
Added value of this study
The current study considered all MAR-conceived children, and adopted a sibling-comparison
model with a fixed-effects specification that is more appropriate (than random-effects models)
for determining whether the MAR treatment had an independent effect on birth outcomes, as
it fully controlled for unobserved parental characteristics shared by siblings. Moreover, it relied
on a uniquely high-quality register dataset that was large enough to facilitate sibling
comparisons, free of loss to follow-up and self-report biases.
Implications of all the available evidence
As a group, children born after MAR are, in absolute terms, at increased risk of adverse birth
outcomes. But the results of the current study indicate that this elevated risk is likely
attributable to factors other than the treatment itself. Understanding the risks associated with
MAR treatment is very important for couples considering using MAR treatment to conceive,
physicians advising patients about the risks of MAR, and public health policy-makers.
4Introduction
Medically Assisted Reproduction (MAR) – i.e., reproduction brought about through treatments
such as ovulation induction, artificial insemination, in vitro fertilization (IVF) or
intracytoplasmic sperm injection (ICSI) with fresh/frozen embryo transfer – is one of the key
achievements of reproductive medicine. The increasing number of children born after MAR,
to date more than five million,1 has motivated research about its impact on the well-being of
children.
While previous studies have consistently found that children born after MAR have worse
perinatal outcomes than children who were conceived naturally,2-6 the mechanisms underlying
this  well-established  association  are  not  fully  understood.  First,  worse  outcomes  could  be
related to the rates of multiple births, which are 10-20 times higher in the MAR subpopulation
than in the general population, and are strong predictors of adverse birth outcomes.7 Second,
the association could be related to parental characteristics that predispose the parents to seek
MAR  treatments  and  to  be  at  high  risk  of  adverse  birth  outcomes,  such  as  subfertility  and
advanced age, which are known risk factors for adverse birth outcomes.4,8,9 However, the risk
of adverse outcomes cannot be entirely attributed to multiple births, as singletons conceived
through  MAR  are  also  at  higher  risk  of  adverse  birth  outcomes  than  singletons  conceived
naturally.3,10 Existing  studies  have  also  found  that  although  subfertility  might  play  a  role  it
cannot be considered as the only explanation for the poorer outcomes of the MAR subgroup
relative to the overall population and that being born to an older mother is not associated with
worse birth outcomes among children conceived through MAR.4,11
Consequently, the literature has suggested that some of the effects could be attributed to the
MAR procedures themselves, 4,12,13 such as the freezing of embryos, the delayed fertilisation
of the oocytes, and the hormonal treatments.14 However, establishing an independent effect
requires isolating the effects of the MAR procedures from the multiple factors that might
confound the association – many unobserved by the researcher. The majority of existing studies
have analysed the association between MAR and birth outcomes by comparing MAR- and
naturally conceived children in different families, and by adjusting for a limited set of observed
characteristics.3,4 The results of such studies may suffer from bias due to residual confounding.
For example, the health of the mother, which may influence the likelihood of adverse birth
outcomes, is unlikely to be fully captured by observed control variables.
This  study  is  the  first  to  analyse  the  potentially  harmful  effects  of  MAR  treatment  using  a
sibling-comparison approach, which enables us to account for all observed and unobserved
parental characteristics shared by siblings.15 We used large-scale Finnish register data to
analyse the association between MAR and birth outcomes within families in which at least one
child was born after MAR and one child was conceived naturally. Three earlier MAR studies
compared siblings, but these studies suffered from two major limitations. First, they relied on
random-effects models, which are biased when unobserved random effects (e.g., measuring
health) are correlated with observed covariates (e.g., socioeconomic status).16 Second, they
focused on children conceived through IVF only, and assigned children born after other fertility
5treatments to the naturally conceived group.17-19 We consider all MAR-conceived children;
adopt a sibling-comparison model with a fixed-effects specification that is best suited for
establishing whether the MAR treatment has an independent effect on birth outcomes; and rely
on a uniquely high-quality register dataset that is large enough to facilitate sibling comparisons,
without loss to follow-up and self-report bias.
Methods
Study population
We used data from Finnish administrative registers covering a 20% random sample of
households with at least one child aged 0–14 at the end of 2000. The linkages between different
registers were carried out by Statistics Finland using personal identification numbers. We
included birth cohorts 1995–2000 because the information  on whether the child was conceived
through MAR or naturally was available from 1995 onwards.
Birth outcomes
Information  on  four  birth  outcomes  was  extracted  from  the  Finnish  Medical  Birth  Register
(MBR): birth weight (in grams), gestational age at birth (in days), and indicators for low birth
weight (LBW, less than 2500g at birth), and whether the child was preterm (less than 37 weeks
of gestation).
Medically Assisted Reproduction (MAR)
We identified children who were conceived through MAR from purchases of prescription
medication using the method developed by Hemminki et al., which has been found to be
reliable.20 There are four main MAR techniques (ovulation induction, artificial insemination,
IVF and ICSI with fresh/frozen embryo transfers) with an associated common pattern of
fertility drugs. We retrieved from the National Prescription Register information on all
prescription medication purchases from Finnish retail pharmacies, regardless of whether the
medication was prescribed in the public or private sector. The Prescription Register provides
information on the day of purchase, the name and class of the drug, and the size and quantity
of packages. By combining each woman’s purchases of fertility drugs with her child’s date of
birth (retrieved from the MBR), we were able to identify children conceived through MAR.
Control variables
We considered a range of child and parental characteristics that are associated with both
conceiving through MAR and with the risk of adverse birth outcomes. The child characteristics
retrieved from the MBR were sex, multiple birth, and birth order (1, 2, 3, or higher of live
births).
The mother’s characteristics included mother’s age at birth (continuous), whether the mother
smoked during pregnancy (binary), deciles of household income, highest level of education in
the household (tertiary or below), and the marital status of the parents. Because the aim of the
study was to isolate the effects of MAR from these of confounders, the models did not include
6adjustments for mediators – e.g, gestational age or gestational hypertension – that could be on
the causal pathway between MAR and birth outcomes.
Statistical analyses
We evaluated the association between MAR and birth outcomes using two approaches. The
standard approach used in the literature consists of analysing the association between MAR
and birth outcomes by comparing children born in different families. In order to account for
confounders, these models included controls for observed child and parental characteristics.
We refer to these models as between-family comparisons.
The alternative approach was based on comparing siblings born to the same parents, but
conceived either naturally or through MAR; we refer to these models as within-family
comparisons. Also known as sibling fixed effects, the within-family model includes an indicator
for each sibling group, and identifies the association between MAR and birth outcomes from
variation between siblings.15 The main advantage of this model is that it fully accounts for
unobserved family characteristics shared by siblings. These unobserved characteristics may,
for  example,  include  subfertility,  which  predisposes  a  couple  to  seek  MAR  treatment  to
conceive and to experience adverse birth outcomes. Observable characteristics that are not
shared by siblings and vary over time, such as family income at the year of birth, were adjusted
for as in standard regression analyses. We did not control for education and marital status of
parents, which show little variation between siblings.
We estimated four regression models using Stata 14 for both the between- and within-family
approaches. We estimated linear models on the continuous outcomes (birth weight and
gestational age) and linear probability models on the binary outcomes (LBW and preterm
birth), in which the model coefficients were interpretable as marginal effects.15 The baseline
model documented the descriptive association between MAR and each of the outcomes. Model
1 introduced controls for the child’s sex and multiple birth, Model 2 introduced controls for
birth order, and Model 3 introduced controls for parental characteristics.4
Children born after MAR are more likely to be first-born or of lower birth orders than their
naturally conceived siblings.8,17,21 Primiparity is associated with increased risk of adverse
perinatal outcomes, and birth weight increases with increasing birth order22. Thus, birth order
could partly explain the poorer birth outcomes of MAR-conceived children. To explore this
possibility, we replicated the within-family analyses (baseline and Model 1) depending on
whether the birth of the MAR-conceived child preceded (n=744) or followed (n=464) the birth
of his/her naturally conceived sibling. For this last set of analyses, when the MAR-conceived
child was born in-between two natural conceptions or when a naturally conceived child was
born in between two MAR births, we only considered the first two births and excluded the third
(or higher order) birth (n=33). We also excluded families (n=2) in which two consecutive
MAR-conceived births were followed by a natural conception, or in which two natural
conceptions were followed by a MAR-conceived birth.
7Inclusion criteria and exclusions
We excluded cases of prescription medication purchases in the special refund category, which
indicates the use of fertility drugs to treat other diagnosed medical conditions, such as cancer.
We excluded births to mothers younger than age 20 (n=1,862) or older than age 45 (n=267)
because it was unclear whether the women in these age groups were using the drugs for
infertility  or  for  other  purposes.  We  dropped  families  with  triplets  (n=44).  We  kept  in  the
analyses siblings who did not have the same father, as they were very small in number (n=4).
Prevalence of missing data was negligible (the variable showing the highest level was smoking
during pregnancy at 4%). The final sample included 65,723 children, 4% (n=2776) of whom
were conceived through MAR. In 578 families, at least one child was conceived through MAR
and one child was conceived naturally (n=1245).
Previous studies using sib-ship designs
Only three other studies have explored the association between MAR and birth outcomes using
sib-ship designs. These studies relied on random-effects models. A key assumption for
unbiased random-effects model is that the individual effects are uncorrelated with observed
independent variables, an assumption that is often untenable.16 To overcome this limitation, we
use fixed-effects models, which do not require any assumption about the correlation between
unobserved fixed effects and observed independent variables, and are thus more appropriate to
fully control for unobserved parental characteristics shared by siblings.16 Prior studies have
also restricted the MAR category to IVF-conceived children only which could bias the MAR
effects towards zero, as children conceived through other MAR treatments have worse birth
outcomes than naturally conceived children.21 To overcome this possible bias we included in
the MAR group children who were conceived through IVF as well as other MAR techniques.
Results
Descriptive analyses
In the between-family analyses, MAR-conceived children had worse birth outcomes than the
naturally conceived children (table 1). For example, the prevalence of LBW was 3·5%
(n=2,203) in the naturally conceived group and 12·8% (n=355) in the MAR-conceived group.
MAR-conceived children were also more likely than naturally conceived children to be the
first-born (61·6% (n=1,710) vs. 37·7% (n=23,731)), and almost 10 times more likely to be a
multiple birth (20·7% (n=575) vs. 2·1% (n=1,322)). Compared to mothers of naturally
conceived children, mothers of MAR-conceived children were, on average, older, better
educated, and less likely to smoke during pregnancy.
In the within-family comparisons, the differences in birth outcomes were reduced, but not
eliminated. For example, 2·9% (n=18) of naturally conceived and 8·6% (n=54) of MAR-
conceived children were LBW.
8Regression results
The between-family results showed that MAR children had significantly worse birth outcomes
than naturally conceived children: on average, they were lighter and born earlier, and were
more likely to be LBW and to be born preterm (Table 2, coefficients for the control variables
presented in Web Tables 1-4). For example, MAR-conceived children were, on average, 266gr
lighter (95% CI: -296 to -235) and 9.8 percentage points (95% CI: 8·1 to 11·4) more likely to
be preterm. The baseline associations were attenuated by around 60-70% when adjustments
were made for sex and multiple births in Model 1; and by around 60-80% when a further
adjustment was made for birth order in Model 2. However, in the fully adjusted Model 3, MAR-
conceived children still had lower birth weight, increased risk of LBW, shorter gestation, and
increased risk of preterm birth (e.g., on average 60gr (95% CI: -85 to -34) lighter and 2·1
percentage points more likely to be preterm (95% CI: 1·1 to 3·2) than naturally conceived
children).
Our within-family comparison of MAR-conceived children with their naturally conceived
siblings showed that the associations were weaker than in the between-family analyses. For
example, in the baseline model, the difference in birth weight was 137g (95% CI: -189 to -85),
and the difference in preterm delivery was four percentage points (95% CI: 1·4 to 6·7). In the
fully adjusted Model 3, the difference in birth weight was only 31g (95% CI: -85 to 22), and
the difference in preterm delivery was 1·6 percentage points (95% CI: -1·6 to 4·4). The patterns
for gestational age and LBW were similar. In the fully adjusted within-family analysis, there
was no evidence of a statistically significant association between MAR and birth any outcome
(figures  1-4).  These  results  were  almost  identical  if  we  excluded  multiple  births  from  the
analytical sample.
MAR children born before their naturally conceived siblings had lower birth weight and
increased probabilities of LBW and preterm delivery (Table 3 and Figure 5). However, among
MAR-conceived children born after their naturally conceived siblings, the association was
reversed for birth weight, and was much smaller and not statistically significant for LBW and
preterm delivery. Following adjustments for the child’s sex and multiple births (Model 1),
MAR-conceived children were 163 gr (95% CI: -220 to -105) lighter if they were born before
their naturally conceived siblings, and 58gr (95% CI: -28 to 144) heavier if they were born
after. Regardless of birth order, MAR-conceived children were, on average, born earlier than
their naturally conceived siblings; but the risk of preterm birth was significantly higher only
among MAR-conceived children born before their naturally conceived siblings.
Discussion
As a group, MAR-conceived children are at elevated risk of having low birth weight and being
born preterm. This excess risk could be due to harmful effects of the treatment or to pre-existing
parental characteristics that confound the association between MAR treatment and birth
outcomes. Our analysis of birth outcomes in families with both MAR-conceived and naturally
conceived children found only limited evidence that the excess risk could be attributed to the
MAR treatment itself. When we compared MAR-conceived children to their naturally
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both statistically and substantively negligible associations between MAR and birth outcomes.
This study has several strengths. First, the dataset was large and allowed us to compare siblings
conceived through MAR and naturally. Second, the data were not prone to self-selection or
self-report bias because they were drawn from administrative registers and have a negligible
level of missingness. Third, we relied on a methodological approach that enabled us to account
for unobserved parental characteristics shared by siblings. Unlike prior studies, which
compared MAR- and naturally conceived children in the same families using random-effects
models, 17-19 we estimated fixed-effects models that fully control for unobserved parental
characteristics shared by siblings, and are thus preferable when the aim is to isolate the effects
of MAR from those of unobserved parental characteristics.16 Moreover, we included in the
MAR group children  who were  conceived  with  treatments  other  than  IVF.  In  prior  studies,
these children were included in the reference category of naturally conceived children.
Our analysis has limitations that are important to note when considering the practical
implications of the findings. First, although the use of the within-family approach minimized
the confounding of unobserved parental characteristics in our estimates, it restricted our ability
to generalize the results to all MAR-conceived children. A particular concern is that parents
who have both MAR- and naturally conceived children are more likely to have used less
invasive treatments, such as ovulation induction, that may not be as strongly associated with
adverse birth outcomes, than more invasive treatments, such as IVF. Because we did not have
access to the National Procedure Register, we could not reliably distinguish all IVF treatments
from the less invasive treatments. A comparison with Hemminki et al.20 indicated that in our
data we underestimated the percentage of IVF-conceived children by about  10%. As a
robustness check we estimated the models separately for the group of IVF-conceived children
(40% of total MAR births), and the results support the main study argument. For the same
reason, we could not distinguish fresh from frozen embryo transfers in IVF/ICSI cycles.23
Whilst the fact that we could not analyze treatment types separately is a limitation, we believe
that it is also justifiable to analyze MAR as a single category because there are a lot of common
characteristics between couples who access different MAR treatments. For example, couples
who seek any MAR treatment are unable to conceive naturally and suffer from sub-fertility, all
treatment types involve some drug therapy, and undergoing any MAR treatment is a stressful
process. Children who are conceived through any MAR treatment are more likely to be multiple
birth and the first born. All these characteristics could negatively affect birth outcomes.
Second, we could not test whether the effects of MAR on birth outcomes vary according to the
length of infertility, medication dose and number of treated cycles. Future work using larger
samples  and  with  longer  follow-up  should  explore  whether  the  effects  of  MAR  on  birth
outcomes vary, for example, by the length of infertility. In addition, further analyses should
evaluate whether the repercussions of MAR on child outcomes have changed over time (for
example, single embryo transfer has become common practice resulting in a drop in multiple
births)2. Finally, further within family fixed-effect analyses should aim to study the relationship
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between MAR treatments and longer term health and social outcomes. Third, the within-family
analyses have lowered the precision of the estimates because they reduced the sample size,
which could in turn mean that the parameters were not statistically significant; the within-
family confidence intervals overlapped with those of the between-family estimates. However,
the within-family associations for all four outcomes showed parameter estimates that were both
statistically and substantially negligible.
The fact that the within-family estimates are smaller than the between-family ones suggest that
the association between MAR and adverse birth outcomes is confounded by unobserved factors
related to both the probability of seeking MAR treatment to conceive and the probability of
adverse birth outcomes. These unobserved factors could be parental underlying health,
subfertility, psychological stress and genetic factors. Three other studies have looked at
families with at least one MAR- and one naturally conceived child. Our results are not fully
comparable to those of previous studies because we used fixed- (instead of random-) effects
models, and we assigned children conceived with treatments other than IVF to the MAR (rather
than the reference) category. Moreover, unlike in previous studies, we did not control for
mediators like gestational age when analysing the association between MAR and birth
weight/LBW. However, despite these differences, our study and these three other studies all
suggest that any MAR-specific effect on birth outcomes (though statistically significant in two
studies 18,19) is small, and is unlikely to be clinically relevant.
The results also point to the importance of considering factors that vary across families and
between siblings. In particular, MAR-conceived children are more likely than naturally
conceived children to be the first-born child. Being the first-born is a known risk factor for
adverse birth outcomes, and our results show that the effect of birth order is stronger than the
effect of MAR in both the between- and within-family analyses. For example, the analyses for
birth weight show that the effect of being the first-born rather than the second- or third-born
was,  respectively,  three  and  four  times  higher  than  the  effect  of  MAR  (Web  Table  1).
Moreover, in the within-family analyses, the association between MAR and birth outcomes
changed substantially based on whether the MAR child was born before or after his/her
naturally conceived sibling. These findings support the argument that the treatments per se
have little or no effect on the risk of adverse birth outcomes, and that any effects that exist are
considerably smaller than the effect of being the first-born. Yet the impact on birth outcomes
of birth order has been much less discussed in the literature than the negative impact of MAR.
The question of whether seeking MAR treatment to conceive increases the risk of adverse
pregnancy outcomes is important given that the utilization of these techniques has been
increasing strongly in virtually all advanced societies since the 1980s.1,24 Understanding these
risks is essential for couples considering using MAR treatments to conceive, physicians
advising patients about the risks of MAR, and public health authorities.  Our results indicate
that children born after MAR are, in absolute terms, at elevated risk of adverse birth outcomes;
but that this higher risk is likely attributable to factors other than the treatment itself.
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Table 1 Birth outcomes and characteristics of women giving birth in Finland in 1995-2000, by mode of conception
Overall population Within-family sample
NC (n=62,947) MAR (n=2,776) P value NC (n=620) MAR (n=625) P value
Birth outcomes
Birth weight in grams, mean (sd) 3551 (556) 3286 (694) p<0.0001 3594 (547) 3428 (665) p<0.0001
Low birth weight (%) 3.5 12.8 p<0.0001 2.9 8.6 p<0.0001
Gestational age in days , mean (sd) 278 (12) 271 (17) p<0.0001 278 (11) 275 (15) p<0.0001
Preterm (%) 4.9 14.6 p<0.0001 4.8 9.4 0.002
Covariates
First-order birth (%) 37.7 61.6 p<0.0001 26.6 47.5 p<0.0001
Maternal age  at birth, mean (sd) 29.6 (5) 32.0 (5) p<0.0001 31.0 (5) 31.0 (4) 0.671
Household income decile, mean (sd) 5.3 (3) 6.3 (3) p<0.0001 5.9 (3) 6.2 (3) 0.04
Household with tertiary education (%) 53.0 65.3 p<0.0001 66.8 68.5 0.593
Parents married the year of the child's birth (%) 66.4 79.4 p<0.0001 82.9 81.6 0.619
Mother smoked during pregnancy (%) 14.4 6.2 p<0.0001 4.2 5.8 0.253
Multiple birth (%) 2.1 20.7 p<0.0001 1.0 10.9 p<0.0001
Child sex: girl (%) 49.1 48.6 0.725 46.3 45.4 0.769
Number of observations 65723 1245
Note: NC=naturally conceived; MAR=conceived with the help of Medically Assisted Reproduction methods. P values obtained through Chi Square test (for all categorical
variables) and t test (for all continuous variables).
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Table 2 MAR coefficients obtained by estimating between- (n=65,723) and within-family (n=1,245) linear models on the birth outcomes of women giving birth in
Finland 1995-2000 (reference category: naturally conceived children)
Baseline  P Value 95% CI
Model 1
= child
sex +
multiple
birth
P Value 95% CI
Model
2=Model
1+ child
birth
order
 P Value 95% CI
Model
3=Model 2+
family
characteristicsa
P Value 95% CI
Between family Birth weight (gr) -266 p<0.0001 -296 - -235 -98 p<0.0001 -124 - -72 -47 p<0.0001 -73 - -22 -60 p<0.0001 -86 - -34
Gestational age
(days) -6 p<0.0001 -7 - -5 -2 p<0.0001 -3 - -2 -2 p<0.0001 -3 - -1 -2 p<0.0001 -3 - -1
LBW
(percentage
points)
9.35 p<0.0001 7.88 - 10.81 2.24 p<0.0001 1.31 - 3.17 1.43 0.003 0.49 - 2.36 1.61 0.001 0.68 - 2.55
Preterm
(percentage
points)
9.75 p<0.0001 8.10 - 11.41 2.78 p<0.0001 1.71 - 3.86 2.01 p<0.0001 0.93 - 3.10 2.15 p<0.0001 1.07 - 3.24
Within family
(sibling fixed
effects)
Birth weight (gr) -137 p<0.0001 -189 - -85 -82 0.001 -132 - -32 -34 0.209 -88 - 19 -31 0.252 -85 - 22
Gestational age
(days) -2 p<0.0001 -4 - -1 -1 0.07 -2 – 0 -1 0.056 -3 - 0 -1 0.059 -3 - 0
LBW
(percentage
points)
4.66 p<0.0001 2.39 - 6.93 2.31 0.019 0.38 - 4.25 1.57 0.138 -0.51 - 3.65 1.42 0.18 -0.66 - 3.51
Preterm
(percentage
points)
4.04 0.003 1.36 - 6.73 2.03 0.107 -0.44 - 4.49 1.54 0.277 -1.24 - 4.31 1.56 0.278 -1.26 - 4.38
Note: a Model 2 includes control for: birth order, maternal age at birth, smoking during pregnancy, household income decile. The between family model also includes
adjustment for parents' marital status and for whether at least one of the two parents holds a tertiary education degree. Reference category: naturally conceived children
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Table 3 Within-family MAR coefficients obtained by estimating linear models on the birth outcomes among women giving birth in Finland 1995-2000, by birth
order of MAR vs. NC conceptions
Baseline P value Model 1 = child sex + multiple birth P value
MAR followed by NC
(n=744) Birth weight (gr) -224 p<0.0001 -163 p<0.0001
Gestational age (days) -2 0.036 0 0.792
LBW 5.49 p<0.0001 2.72 0.029
Preterm 4.93 0.007 2.11 0.195
NC followed by MAR
(n=464) Birth weight (gr) 8 0.845 58 0.183
Gestational age (days) -4 0.001 -2 0.019
LBW 3.36 0.061 1.36 0.398
Preterm 2.31 0.29 1.30 0.522
Note: NC=naturally conceived; MAR=conceived through the help of Medically Assisted Reproduction. Reference category: naturally conceived children
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Figure 1 Mean birth weight for MAR children (reference: naturally conceived)  from estimating between- and within-family models for women giving birth in
Finland 1995-2000 (Table 2), with 95% confidence intervals
Figure 2 Mean gestational age for MAR children (reference: naturally conceived)  from between- and within-family models for women giving birth in Finland
1995-2000 (Table 2), with 95% confidence intervals
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Figure 3 Percentage change in the probability of LBW for MAR children (reference: naturally conceived) from between- and within-family models for women
giving birth in Finland 1995-2000 (Table 2), with 95% confidence intervals
Figure 4 Percentage change in the probability of preterm birth for MAR (reference: naturally conceived)  children from between- and within-family models for
women giving birth in Finland 1995-2000 (Table 2), with 95% confidence intervals
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Figure 5 Mean birth weight for MAR children from within-family models, by birth order of MAR and naturally conceived siblings for women giving birth in
Finland 1995-2000 (Table 3), with 95% confidence intervals
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